PCa cells with BRCA2 KD also showed increased sensitivity to Cyst(e)inase treatment with reduced survival compared to corresponding BRCA2 proficient PCa cells treated with the enzyme (Fig. 6E). This evidence concerns the gene BRCA2 and posterior cortical atrophy.